FDA MoCRA Requirements Before Selling Cosmetics in the US

What happens if I sell cosmetics in the US without MoCRA compliance, and what are the FDA enforcement risks?

By Blake Mereby · Last reviewed November 1, 2026

Selling cosmetics in the US without MoCRA compliance is a violation of federal law, and the FDA has significant enforcement authority under the Modernization of Cosmetics Regulation Act. Enforcement action can range from a warning letter to product seizure, import detention, and legal prosecution in severe or repeat cases. Understanding the realistic risks will help you prioritize compliance before launch.

The most common first step is an FDA warning letter. If the agency becomes aware of a non-compliant cosmetic — through social media monitoring, consumer complaints, import inspections, or industry tips — they send a letter detailing the violations and requesting corrective action within a specified timeframe (usually 15 days). Common violations include failure to register the facility, failure to list the product, missing or incomplete ingredient labeling, and lack of safety substantiation. A warning letter does not immediately halt sales, but it creates a legal record of non-compliance. If you ignore it or don't remedy the violations, enforcement escalates. A warning letter also damages credibility: retailers see it and may refuse to stock your product, and the letter is public (posted on the FDA website), affecting brand reputation and consumer trust.

Product seizure is a more serious enforcement action. If the FDA finds that a cosmetic is adulterated or misbranded (e.g., lacks a required ingredient statement or can't produce safety data), federal marshals can seize inventory at manufacturing facilities, warehouses, or retail locations. Your products are then held in government custody, and you must prove compliance or they're destroyed. Seizure can happen at the border if your product arrives in a US port — many indie brands manufacturing overseas discover this when their shipment is held and they're asked to provide facility registration, product listings, and safety data within days. If you can't produce these documents immediately, the shipment is refused entry and may be returned to the origin or destroyed.

Import detention is another critical risk for brands manufacturing outside the US. If the FDA has reason to believe a product violates MoCRA, they can place an import alert on that product or facility, meaning every shipment is detained for FDA review before entry. This can delay product arrival by weeks or even months and is extremely costly for small inventory runs. A single detained shipment can wipe out profit margins for an indie founder.

Adverse event reporting violations carry their own penalties. If a consumer reports that your cosmetic caused skin irritation or injury and you fail to document and report it to the FDA when required, you're in violation. The FDA can issue a warning letter or fine. More importantly, if your product causes genuine harm and you haven't been tracking adverse events, your liability exposure increases dramatically — a personal injury lawsuit will reveal that you had no safety file and no adverse event monitoring system.

Label and claim violations are frequently cited. If your label includes unsubstantiated claims (e.g., "clinically proven to reduce wrinkles" without supporting data) or missing required elements (no ingredient declaration, no net quantity, no manufacturer address), the FDA treats this as misbranding. Even if your formula is safe, a label violation is a violation, and it can be the reason your product is held at import or your shipment is refused.

The practical consequences for indie founders are severe. A single warning letter or import detention can exhaust your cash reserves, delay launch by months, and force you to reformulate or abandon the product entirely. If you've pre-sold to customers or retailers, a seized shipment creates legal liability and reputational damage. Additionally, FDA enforcement actions are public and searchable online — a warning letter against your brand is discovered by investors, retail partners, and future customers, making it difficult to rebuild trust.

Regional and marketplace complications arise as well. Amazon, Sephora, Ulta, and other major retailers require proof of FDA compliance (facility registration and product listing numbers) before they'll accept your product. If you can't provide these, you're restricted to smaller independent retailers, beauty boxes, or direct-to-consumer sales. International shipping is also complicated: Canada, the EU, and Australia have their own cosmetics regulations (Health Canada's Natural and Non-prescription Health Products Directorate, the EU's banned-substance list, TGA in Australia), and products non-compliant with US MoCRA may also fail in these markets.

The most common scenario for indie founders is discovering non-compliance too late — after inventory has been manufactured or even after some sales. At that point, the cost and timeline to achieve compliance retroactively is much higher. A chemist on AJ Cosmo Labs can help you audit your current compliance status and create a remediation plan if you're already in this position, but proactive compliance before manufacturing always costs less and poses far lower risk. If you're still in the formulation or pre-manufacturing phase, work with a vetted chemist to design for compliance from day one.

Read the full guide on FDA MoCRA Requirements Before Selling Cosmetics in the US →

More about FDA MoCRA Requirements Before Selling Cosmetics in the US

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app